Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome

Authors Information
Article Notes and Dates
To Cite : Mele M, Rolighed L, Jespersen M, Rejnmark L, Christiansen P. et al. Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome, Int J Endocrinol Metab. 2016 ;14(2):e35424. doi: 10.5812/ijem.35424.
Copyright: Copyright © 2016, International Journal of Endocrinology and Metabolism. .
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Bilezikian JP, Khan AA, Potts Jr JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009; 94(2): 335-9
  • 2. Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of hyperparathyroidism. J Clin Pathol. 2015; 68(10): 771-87[DOI][PubMed]
  • 3. Sarquis MS, Silveira LG, Pimenta FJ, Dias EP, Teh BT, Friedman E, et al. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery. 2008; 143(5): 630-40[DOI][PubMed]
  • 4. Abdulla AG, O'Leary EM, Isorena JP, Diaz MF, Yeh MW. Recurrent hyperparathyroidism and a novel nonsense mutation in a patient with hyperparathyriodism-jaw tumor syndrome. Endocr Pract. 2013; 19(6)-7[DOI][PubMed]
  • 5. Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, Teh BT. Hyperparathyroidism-jaw tumour syndrome. J Intern Med. 2003; 253(6): 634-42[PubMed]
  • 6. Masi G, Barzon L, Iacobone M, Viel G, Porzionato A, Macchi V, et al. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer. 2008; 15(4): 1115-26[DOI][PubMed]
  • 7. Frank-Raue K, Haag C, Schulze E, Keuser R, Raue F, Dralle H, et al. CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum. Eur J Endocrinol. 2011; 165(3): 477-83[DOI][PubMed]
  • 8. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002; 32(4): 676-80[DOI][PubMed]
  • 9. Gill AJ. Understanding the genetic basis of parathyroid carcinoma. Endocr Pathol. 2014; 25(1): 30-4[DOI][PubMed]
  • 10. Kruijff S, Sidhu SB, Sywak MS, Gill AJ, Delbridge LW. Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol. 2014; 21(2): 426-33[DOI][PubMed]
  • 11. Sharretts JM, Kebebew E, Simonds WF. Parathyroid cancer. Semin Oncol. 2010; 37(6): 580-90[DOI][PubMed]
  • 12. Mehta A, Patel D, Rosenberg A, Boufraqech M, Ellis RJ, Nilubol N, et al. Hyperparathyroidism-jaw tumor syndrome: Results of operative management. Surgery. 2014; 156(6): 1315-24[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check